Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge.
Jaber S, Winer I, and Rasool N. Recurrent omental hemangiopericytoma: A therapeutic challenge. Case Rep Obstet Gynecol 2016; 2016:2075157.
Case Rep Obstet Gynecol
Hemangiopericytomas are vascular tumors with a susceptibility to arise anywhere in the human body. We present a case of a 68-year-old female with primary omental hemangiopericytoma and a two-time recurrence managed with surgery and close follow-up. The first recurrence was at 52 months and the second at 37 months following the prior presentation. No adjuvant chemotherapy or radiation therapy was administered. Given the widespread nature of the cell of origin, routine follow-up postoperatively with interval imaging in order to detect recurrences is imperative. Pathologic tumor characteristics may determine potential for recurrence and may also assist in determining whether adjuvant treatment modalities should be included in the management plan. Review of the English literature reveals a total of 24 cases of omental hemangiopericytomas inclusive of the current report.